Back

Tailored clinical management after blinded statin challenge improved long-term lipid control in coronary patients with self-perceived muscle side-effects

15 April 2021 (08:00 - 19:20)
Organised by:
Congress Presentation Part of: ePosters Drug therapy EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Doctor Elise Sverre

Vestre Viken HF, Drammen Hospital, Drammen (Norway)

334 More presentations in this session

Presentation thumbnail
A diet-related microsimulation modelling approach in the context of cardiovascular disease prevention: the ATTICA and GREECS epidemiological studies.
Professor D. Panagiotakos (Athens, GR)
Abstract Slides
Presentation thumbnail
s-VCAM-1 is an independent predictor of all-cause mortality in patients with dilated cardiomyopathy and hypokinetic non-dilated cardiomyopathy
Doctor K. Lehnert (Greifswald, DE)
Abstract Slides
Presentation thumbnail
Age-standardized prevalence of social determinants of health and associated race-ethnic disparities in stroke survivors
Doctor T. Parekh (Newark, US)
Abstract Slides
Presentation thumbnail
Impact of Proteinuria and Low eGFR on Lifetime Risk of Cardiovascular Disease Death: A Pooled Analysis of Data From the Evidence for Cardiovascular Prevention From Observational Cohorts in Japan Study
Ms Y. Imai (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Risk of cerebrovascular accidents according to weather and pollution features
Associate Professor G. Biondi-Zoccai (Latina, IT)
Abstract Slides

Access the full session

Session thumbnail
ePosters

The Event

Event poster

ESC Preventive Cardiology 2021

15 April 2021 08:00 CET
You may be interested in
thumbnail
Congress Presentation
Step by step diagnosis and management of statin intolerance: position paper from an international lipid expert panel.
31 August 2019
thumbnail
Congress Presentation
Sex-related differences regarding results of lipid-lowering therapies, implemented through telematic consultation, after an acute coronary syndrome.
13 April 2023
thumbnail
Congress Presentation
Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
28 August 2020
thumbnail
Congress Presentation
Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources